 | • レポートコード：QYR2104Z1800 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、うつ病性障害のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（三環系抗うつ薬、選択的セロトニン再取り込み阻害薬、セロトニン-ノルエピネフリン再取り込み阻害薬、モノアミン酸化酵素阻害薬、セロトニン拮抗薬・再取り込み阻害薬、その他）、用途別市場規模（病院、外来手術センター、診断センター、在宅医療施設、介護センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・うつ病性障害の市場動向 ・企業の競争状況、市場シェア ・うつ病性障害の種類別市場規模（三環系抗うつ薬、選択的セロトニン再取り込み阻害薬、セロトニン-ノルエピネフリン再取り込み阻害薬、モノアミン酸化酵素阻害薬、セロトニン拮抗薬・再取り込み阻害薬、その他） ・うつ病性障害の用途別市場規模（病院、外来手術センター、診断センター、在宅医療施設、介護センター） ・うつ病性障害の北米市場規模2016-2027（アメリカ、カナダ） ・うつ病性障害のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・うつ病性障害のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・うつ病性障害の中南米市場規模2016-2027（メキシコ、ブラジル） ・うつ病性障害の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Alkermes、Allergan、Bristol Myers Squibb、Eli Lilly、Glaxosmithkline、H. Lundbeck、Merck、Pfizer、Teva Pharmaceutical、Takeda Pharmaceutical） ・結論 |
Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including genes, factors such as stress and brain chemistry that could lead to depression.
The Depressive Disorder market will undergo a period of steady growth from 2015 to 2025, mainly attributed to the growth in atypical antipsychotics and the expected launch of five pipeline.
Market Analysis and Insights: Global Depressive Disorder Market
The global Depressive Disorder market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Depressive Disorder market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Depressive Disorder market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Depressive Disorder market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Depressive Disorder market.
Global Depressive Disorder Scope and Market Size
Depressive Disorder market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Depressive Disorder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Serotonin-Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Serotonin Antagonist And Reuptake Inhibitors
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Homecare Settings
Long Term Care Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Alkermes
Allergan
Bristol Myers Squibb
Eli Lilly
Glaxosmithkline
H. Lundbeck
Merck
Pfizer
Teva Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Depressive Disorder Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tricyclic Antidepressants
1.2.3 Selective Serotonin Reuptake Inhibitors
1.2.4 Serotonin-Norepinephrine Reuptake Inhibitors
1.2.5 Monoamine Oxidase Inhibitors
1.2.6 Serotonin Antagonist And Reuptake Inhibitors
1.2.7 Others
1.3 Market by Application
1.3.1 Global Depressive Disorder Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.3.5 Homecare Settings
1.3.6 Long Term Care Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Depressive Disorder Market Perspective (2016-2027)
2.2 Depressive Disorder Growth Trends by Regions
2.2.1 Depressive Disorder Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Depressive Disorder Historic Market Share by Regions (2016-2021)
2.2.3 Depressive Disorder Forecasted Market Size by Regions (2022-2027)
2.3 Depressive Disorder Industry Dynamic
2.3.1 Depressive Disorder Market Trends
2.3.2 Depressive Disorder Market Drivers
2.3.3 Depressive Disorder Market Challenges
2.3.4 Depressive Disorder Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Depressive Disorder Players by Revenue
3.1.1 Global Top Depressive Disorder Players by Revenue (2016-2021)
3.1.2 Global Depressive Disorder Revenue Market Share by Players (2016-2021)
3.2 Global Depressive Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Depressive Disorder Revenue
3.4 Global Depressive Disorder Market Concentration Ratio
3.4.1 Global Depressive Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Depressive Disorder Revenue in 2020
3.5 Depressive Disorder Key Players Head office and Area Served
3.6 Key Players Depressive Disorder Product Solution and Service
3.7 Date of Enter into Depressive Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Depressive Disorder Breakdown Data by Type
4.1 Global Depressive Disorder Historic Market Size by Type (2016-2021)
4.2 Global Depressive Disorder Forecasted Market Size by Type (2022-2027)
5 Depressive Disorder Breakdown Data by Application
5.1 Global Depressive Disorder Historic Market Size by Application (2016-2021)
5.2 Global Depressive Disorder Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Depressive Disorder Market Size (2016-2027)
6.2 North America Depressive Disorder Market Size by Type
6.2.1 North America Depressive Disorder Market Size by Type (2016-2021)
6.2.2 North America Depressive Disorder Market Size by Type (2022-2027)
6.2.3 North America Depressive Disorder Market Size by Type (2016-2027)
6.3 North America Depressive Disorder Market Size by Application
6.3.1 North America Depressive Disorder Market Size by Application (2016-2021)
6.3.2 North America Depressive Disorder Market Size by Application (2022-2027)
6.3.3 North America Depressive Disorder Market Size by Application (2016-2027)
6.4 North America Depressive Disorder Market Size by Country
6.4.1 North America Depressive Disorder Market Size by Country (2016-2021)
6.4.2 North America Depressive Disorder Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Depressive Disorder Market Size (2016-2027)
7.2 Europe Depressive Disorder Market Size by Type
7.2.1 Europe Depressive Disorder Market Size by Type (2016-2021)
7.2.2 Europe Depressive Disorder Market Size by Type (2022-2027)
7.2.3 Europe Depressive Disorder Market Size by Type (2016-2027)
7.3 Europe Depressive Disorder Market Size by Application
7.3.1 Europe Depressive Disorder Market Size by Application (2016-2021)
7.3.2 Europe Depressive Disorder Market Size by Application (2022-2027)
7.3.3 Europe Depressive Disorder Market Size by Application (2016-2027)
7.4 Europe Depressive Disorder Market Size by Country
7.4.1 Europe Depressive Disorder Market Size by Country (2016-2021)
7.4.2 Europe Depressive Disorder Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Depressive Disorder Market Size (2016-2027)
8.2 Asia-Pacific Depressive Disorder Market Size by Type
8.2.1 Asia-Pacific Depressive Disorder Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Depressive Disorder Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Depressive Disorder Market Size by Type (2016-2027)
8.3 Asia-Pacific Depressive Disorder Market Size by Application
8.3.1 Asia-Pacific Depressive Disorder Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Depressive Disorder Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Depressive Disorder Market Size by Application (2016-2027)
8.4 Asia-Pacific Depressive Disorder Market Size by Region
8.4.1 Asia-Pacific Depressive Disorder Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Depressive Disorder Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Depressive Disorder Market Size (2016-2027)
9.2 Latin America Depressive Disorder Market Size by Type
9.2.1 Latin America Depressive Disorder Market Size by Type (2016-2021)
9.2.2 Latin America Depressive Disorder Market Size by Type (2022-2027)
9.2.3 Latin America Depressive Disorder Market Size by Type (2016-2027)
9.3 Latin America Depressive Disorder Market Size by Application
9.3.1 Latin America Depressive Disorder Market Size by Application (2016-2021)
9.3.2 Latin America Depressive Disorder Market Size by Application (2022-2027)
9.3.3 Latin America Depressive Disorder Market Size by Application (2016-2027)
9.4 Latin America Depressive Disorder Market Size by Country
9.4.1 Latin America Depressive Disorder Market Size by Country (2016-2021)
9.4.2 Latin America Depressive Disorder Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Depressive Disorder Market Size (2016-2027)
10.2 Middle East & Africa Depressive Disorder Market Size by Type
10.2.1 Middle East & Africa Depressive Disorder Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Depressive Disorder Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Depressive Disorder Market Size by Type (2016-2027)
10.3 Middle East & Africa Depressive Disorder Market Size by Application
10.3.1 Middle East & Africa Depressive Disorder Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Depressive Disorder Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Depressive Disorder Market Size by Application (2016-2027)
10.4 Middle East & Africa Depressive Disorder Market Size by Country
10.4.1 Middle East & Africa Depressive Disorder Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Depressive Disorder Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alkermes
11.1.1 Alkermes Company Details
11.1.2 Alkermes Business Overview
11.1.3 Alkermes Depressive Disorder Introduction
11.1.4 Alkermes Revenue in Depressive Disorder Business (2016-2021)
11.1.5 Alkermes Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Depressive Disorder Introduction
11.2.4 Allergan Revenue in Depressive Disorder Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Details
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb Depressive Disorder Introduction
11.3.4 Bristol Myers Squibb Revenue in Depressive Disorder Business (2016-2021)
11.3.5 Bristol Myers Squibb Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Depressive Disorder Introduction
11.4.4 Eli Lilly Revenue in Depressive Disorder Business (2016-2021)
11.4.5 Eli Lilly Recent Development
11.5 Glaxosmithkline
11.5.1 Glaxosmithkline Company Details
11.5.2 Glaxosmithkline Business Overview
11.5.3 Glaxosmithkline Depressive Disorder Introduction
11.5.4 Glaxosmithkline Revenue in Depressive Disorder Business (2016-2021)
11.5.5 Glaxosmithkline Recent Development
11.6 H. Lundbeck
11.6.1 H. Lundbeck Company Details
11.6.2 H. Lundbeck Business Overview
11.6.3 H. Lundbeck Depressive Disorder Introduction
11.6.4 H. Lundbeck Revenue in Depressive Disorder Business (2016-2021)
11.6.5 H. Lundbeck Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Depressive Disorder Introduction
11.7.4 Merck Revenue in Depressive Disorder Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Depressive Disorder Introduction
11.8.4 Pfizer Revenue in Depressive Disorder Business (2016-2021)
11.8.5 Pfizer Recent Development
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Details
11.9.2 Teva Pharmaceutical Business Overview
11.9.3 Teva Pharmaceutical Depressive Disorder Introduction
11.9.4 Teva Pharmaceutical Revenue in Depressive Disorder Business (2016-2021)
11.9.5 Teva Pharmaceutical Recent Development
11.10 Takeda Pharmaceutical
11.10.1 Takeda Pharmaceutical Company Details
11.10.2 Takeda Pharmaceutical Business Overview
11.10.3 Takeda Pharmaceutical Depressive Disorder Introduction
11.10.4 Takeda Pharmaceutical Revenue in Depressive Disorder Business (2016-2021)
11.10.5 Takeda Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Depressive Disorder Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tricyclic Antidepressants
Table 3. Key Players of Selective Serotonin Reuptake Inhibitors
Table 4. Key Players of Serotonin-Norepinephrine Reuptake Inhibitors
Table 5. Key Players of Monoamine Oxidase Inhibitors
Table 6. Key Players of Serotonin Antagonist And Reuptake Inhibitors
Table 7. Key Players of Others
Table 8. Global Depressive Disorder Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Depressive Disorder Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Depressive Disorder Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Depressive Disorder Market Share by Regions (2016-2021)
Table 12. Global Depressive Disorder Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Depressive Disorder Market Share by Regions (2022-2027)
Table 14. Depressive Disorder Market Trends
Table 15. Depressive Disorder Market Drivers
Table 16. Depressive Disorder Market Challenges
Table 17. Depressive Disorder Market Restraints
Table 18. Global Depressive Disorder Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Depressive Disorder Market Share by Players (2016-2021)
Table 20. Global Top Depressive Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Depressive Disorder as of 2020)
Table 21. Ranking of Global Top Depressive Disorder Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Depressive Disorder Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Depressive Disorder Product Solution and Service
Table 25. Date of Enter into Depressive Disorder Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Depressive Disorder Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Depressive Disorder Revenue Market Share by Type (2016-2021)
Table 29. Global Depressive Disorder Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Depressive Disorder Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Depressive Disorder Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Depressive Disorder Revenue Market Share by Application (2016-2021)
Table 33. Global Depressive Disorder Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Depressive Disorder Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Depressive Disorder Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Depressive Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Depressive Disorder Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Depressive Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Depressive Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Depressive Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Depressive Disorder Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Depressive Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Depressive Disorder Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Depressive Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Depressive Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Depressive Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Depressive Disorder Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Depressive Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Depressive Disorder Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Depressive Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Depressive Disorder Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Depressive Disorder Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Depressive Disorder Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Depressive Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Depressive Disorder Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Depressive Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Depressive Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Depressive Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Depressive Disorder Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Depressive Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Depressive Disorder Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Depressive Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Depressive Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Depressive Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 65. Alkermes Company Details
Table 66. Alkermes Business Overview
Table 67. Alkermes Depressive Disorder Product
Table 68. Alkermes Revenue in Depressive Disorder Business (2016-2021) & (US$ Million)
Table 69. Alkermes Recent Development
Table 70. Allergan Company Details
Table 71. Allergan Business Overview
Table 72. Allergan Depressive Disorder Product
Table 73. Allergan Revenue in Depressive Disorder Business (2016-2021) & (US$ Million)
Table 74. Allergan Recent Development
Table 75. Bristol Myers Squibb Company Details
Table 76. Bristol Myers Squibb Business Overview
Table 77. Bristol Myers Squibb Depressive Disorder Product
Table 78. Bristol Myers Squibb Revenue in Depressive Disorder Business (2016-2021) & (US$ Million)
Table 79. Bristol Myers Squibb Recent Development
Table 80. Eli Lilly Company Details
Table 81. Eli Lilly Business Overview
Table 82. Eli Lilly Depressive Disorder Product
Table 83. Eli Lilly Revenue in Depressive Disorder Business (2016-2021) & (US$ Million)
Table 84. Eli Lilly Recent Development
Table 85. Glaxosmithkline Company Details
Table 86. Glaxosmithkline Business Overview
Table 87. Glaxosmithkline Depressive Disorder Product
Table 88. Glaxosmithkline Revenue in Depressive Disorder Business (2016-2021) & (US$ Million)
Table 89. Glaxosmithkline Recent Development
Table 90. H. Lundbeck Company Details
Table 91. H. Lundbeck Business Overview
Table 92. H. Lundbeck Depressive Disorder Product
Table 93. H. Lundbeck Revenue in Depressive Disorder Business (2016-2021) & (US$ Million)
Table 94. H. Lundbeck Recent Development
Table 95. Merck Company Details
Table 96. Merck Business Overview
Table 97. Merck Depressive Disorder Product
Table 98. Merck Revenue in Depressive Disorder Business (2016-2021) & (US$ Million)
Table 99. Merck Recent Development
Table 100. Pfizer Company Details
Table 101. Pfizer Business Overview
Table 102. Pfizer Revenue in Depressive Disorder Business (2016-2021) & (US$ Million)
Table 103. Pfizer Recent Development
Table 104. Teva Pharmaceutical Company Details
Table 105. Teva Pharmaceutical Business Overview
Table 106. Teva Pharmaceutical Depressive Disorder Product
Table 107. Teva Pharmaceutical Revenue in Depressive Disorder Business (2016-2021) & (US$ Million)
Table 108. Teva Pharmaceutical Recent Development
Table 109. Takeda Pharmaceutical Company Details
Table 110. Takeda Pharmaceutical Business Overview
Table 111. Takeda Pharmaceutical Depressive Disorder Product
Table 112. Takeda Pharmaceutical Revenue in Depressive Disorder Business (2016-2021) & (US$ Million)
Table 113. Takeda Pharmaceutical Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Depressive Disorder Market Share by Type: 2020 VS 2027
Figure 2. Tricyclic Antidepressants Features
Figure 3. Selective Serotonin Reuptake Inhibitors Features
Figure 4. Serotonin-Norepinephrine Reuptake Inhibitors Features
Figure 5. Monoamine Oxidase Inhibitors Features
Figure 6. Serotonin Antagonist And Reuptake Inhibitors Features
Figure 7. Others Features
Figure 8. Global Depressive Disorder Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Diagnostic Centers Case Studies
Figure 12. Homecare Settings Case Studies
Figure 13. Long Term Care Centers Case Studies
Figure 14. Depressive Disorder Report Years Considered
Figure 15. Global Depressive Disorder Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Depressive Disorder Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Depressive Disorder Market Share by Regions: 2020 VS 2027
Figure 18. Global Depressive Disorder Market Share by Regions (2022-2027)
Figure 19. Global Depressive Disorder Market Share by Players in 2020
Figure 20. Global Top Depressive Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Depressive Disorder as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Depressive Disorder Revenue in 2020
Figure 22. Global Depressive Disorder Revenue Market Share by Type (2016-2021)
Figure 23. Global Depressive Disorder Revenue Market Share by Type (2022-2027)
Figure 24. North America Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Depressive Disorder Market Share by Type (2016-2027)
Figure 26. North America Depressive Disorder Market Share by Application (2016-2027)
Figure 27. North America Depressive Disorder Market Share by Country (2016-2027)
Figure 28. United States Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Depressive Disorder Market Share by Type (2016-2027)
Figure 32. Europe Depressive Disorder Market Share by Application (2016-2027)
Figure 33. Europe Depressive Disorder Market Share by Country (2016-2027)
Figure 34. Germany Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Depressive Disorder Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Depressive Disorder Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Depressive Disorder Market Share by Region (2016-2027)
Figure 44. China Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Depressive Disorder Market Share by Type (2016-2027)
Figure 52. Latin America Depressive Disorder Market Share by Application (2016-2027)
Figure 53. Latin America Depressive Disorder Market Share by Country (2016-2027)
Figure 54. Mexico Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Depressive Disorder Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Depressive Disorder Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Depressive Disorder Market Share by Country (2016-2027)
Figure 60. Turkey Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Depressive Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Alkermes Revenue Growth Rate in Depressive Disorder Business (2016-2021)
Figure 64. Allergan Revenue Growth Rate in Depressive Disorder Business (2016-2021)
Figure 65. Bristol Myers Squibb Revenue Growth Rate in Depressive Disorder Business (2016-2021)
Figure 66. Eli Lilly Revenue Growth Rate in Depressive Disorder Business (2016-2021)
Figure 67. Glaxosmithkline Revenue Growth Rate in Depressive Disorder Business (2016-2021)
Figure 68. H. Lundbeck Revenue Growth Rate in Depressive Disorder Business (2016-2021)
Figure 69. Merck Revenue Growth Rate in Depressive Disorder Business (2016-2021)
Figure 70. Pfizer Revenue Growth Rate in Depressive Disorder Business (2016-2021)
Figure 71. Teva Pharmaceutical Revenue Growth Rate in Depressive Disorder Business (2016-2021)
Figure 72. Takeda Pharmaceutical Revenue Growth Rate in Depressive Disorder Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の慢性うつ病パーソナリティ障害治療市場規模・現状・予測（2021年-2027年） Chronic depressive personality disorder also known as Dysthymia is a chronic form of depression. It is mild form of depression which last up to two years or more. This disorder is less severe in comparison to other forms of depression. Symptoms of chronic depressive personality disorder are loss of …- 世界の双極性障害治療市場規模・現状・予測（2021年-2027年） Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood. The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics. Market Analysis and Insights: Global Bipolar…
- 世界の可逆性モノアミン系抗うつ阻害剤（RIMA）市場規模・現状・予測（2021年-2027年） RIMAs are used as antidepressants. They work by reducing the activity of monoamine oxidase which is a chemical found throughout the body. Monoamine oxidase breaks down noradrenaline (also called norepinephrine) and serotonin and other chemicals made and used by the body and brain. These chemicals ar…
- 世界の産後うつ病治療薬市場規模・現状・予測（2021年-2027年） Postpartum depression is a prevalent disorder affecting many women of reproductive age. Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depre…
- 世界の大うつ病性障害市場規模・現状・予測（2021年-2027年） Major depressive disorder, also known as major depression and clinical depression, is a mental disorder characterized by loss of interest and pleasure in enjoyable environment. People are affected in different ways by major depression. Some people have trouble sleeping, feel agitated and irritable, …